Sign Up to like & get
recommendations!
1
Published in 2021 at "Archiv der Pharmazie"
DOI: 10.1002/ardp.202000491
Abstract: The anticancer activity of novel thiazolidine‐2,4‐diones was evaluated against HepG2, HCT‐116, and MCF‐7 cells. Among the tested cancer cell lines, HCT‐116 was the most sensitive one to the cytotoxic effect of the new derivatives. In…
read more here.
Keywords:
hct 116;
vegfr inhibitors;
admet profile;
anticancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Archiv der Pharmazie"
DOI: 10.1002/ardp.202100487
Abstract: Novel triazoloquinazolines were designed and synthesized and evaluated as anticancer agents against HepG2 and HCT-116 cells. The biological testing data corresponded well to those of the molecular docking studies. The HCT-116 cell line was most…
read more here.
Keywords:
dna;
molecular docking;
admet profile;
binding activities ... See more keywords